Advertisement

The Scientist

» clinical trials

Most Recent

image: Not All Stem Cells Created Equal

Not All Stem Cells Created Equal

By | July 2, 2014

Compared to induced pluripotent stem cells generated from somatic cells, stem cells created by nuclear transfer appear to be closer to the genetic state of embryonic cells.

1 Comment

image: Accidental Orgasms

Accidental Orgasms

By | July 1, 2014

Meet the researcher struggling to gain approval for his medical device, which was originally designed to relieve back pain, but turned out to be an orgasm inducer.

1 Comment

image: That Loving Feeling

That Loving Feeling

By | July 1, 2014

There are no FDA-approved drugs to treat low sexual desire in women, but not for lack of trying.

0 Comments

image: Medical Marijuana: Where’s the Data?

Medical Marijuana: Where’s the Data?

By | June 30, 2014

As more states legalize therapeutic cannabis, some caution against overprescribing the drug, the benefits of which have not been rigorously tested in clinical trials.

2 Comments

image: Week in Review: June 16–20

Week in Review: June 16–20

By | June 20, 2014

Early Neanderthal evolution; developing antivirals to combat polio; the mouth and skin microbiomes; insect-inspired, flight-stabilizing sensors

0 Comments

image: Opinion: Thwarting Medical Tourism

Opinion: Thwarting Medical Tourism

By | June 17, 2014

It’s time to take a strong stance against unregistered cellular therapies, which can undermine legitimate research efforts.

0 Comments

image: To Finish Off Polio

To Finish Off Polio

By | June 17, 2014

Along with vaccination, antiviral drugs could play a key role in the eradication of poliovirus, but it’s unclear whether today’s candidate therapies will withstand the challenges of the clinic.

0 Comments

image: EMA Gearing Up for Transparency

EMA Gearing Up for Transparency

By | June 16, 2014

The European Medicines Agency is preparing for a new policy that will release rarely-seen clinical trial reports for independent scrutiny.  

0 Comments

image: Geron hESC Trial to Resume?

Geron hESC Trial to Resume?

By | May 27, 2014

Nearly three years after Geron shuttered its stem cell program, BioTime receives funding to relaunch a Phase 1 trial for spinal cord injury.

0 Comments

image: NIH Accused of Interfering with Ethics Probe

NIH Accused of Interfering with Ethics Probe

By | May 21, 2014

A watchdog group claims that the federal agency improperly influenced the investigation of a study involving the treatment of preterm infants.

3 Comments

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Culture Techniques
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
Advertisement
Mettler Toledo
BD Biosciences
BD Biosciences